BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20169144)

  • 1. Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.
    Antoniou KM; Soufla G; Proklou A; Margaritopoulos G; Choulaki C; Lymbouridou R; Samara KD; Spandidos DA; Siafakas NM
    Clin Dev Immunol; 2009; 2009():537929. PubMed ID: 20169144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of stromal cell derived factor-1alpha in collagen vascular diseases-associated interstitial pneumonias (CVDs-IPs).
    Margaritopoulos GA; Antoniou KM; Soufla G; Karagiannis K; Proklou A; Lasithiotaki I; Tzanakis N; Spandidos DA; Siafakas NM
    Pulm Pharmacol Ther; 2010 Apr; 23(2):115-20. PubMed ID: 19878731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis.
    Antoniou KM; Tzouvelekis A; Alexandrakis MG; Sfiridaki K; Tsiligianni I; Rachiotis G; Tzanakis N; Bouros D; Milic-Emili J; Siafakas NM
    Chest; 2006 Oct; 130(4):982-8. PubMed ID: 17035428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis.
    Paplińska-Goryca M; Goryca K; Misiukiewicz-Stępień P; Nejman-Gryz P; Proboszcz M; Górska K; Maskey-Warzęchowska M; Krenke R
    Eur J Clin Invest; 2019 Sep; 49(9):e13153. PubMed ID: 31246273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis.
    Antoniou KM; Soufla G; Lymbouridou R; Economidou F; Lasithiotaki I; Manousakis M; Drositis I; Spandidos DA; Siafakas NM
    Connect Tissue Res; 2010; 51(1):71-80. PubMed ID: 20067420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatic versus angiogenic chemokines in IPF and EAA.
    Martina S; Martina V; Monika M; Jan P; Libor K; Ilja S
    Respir Med; 2009 Nov; 103(11):1651-6. PubMed ID: 19535235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients.
    Antoniou KM; Tzanakis N; Tzortzaki EG; Malagari K; Koutsopoulos AV; Alexandrakis M; Wells AU; Siafakas NM
    Pulm Pharmacol Ther; 2008 Dec; 21(6):840-4. PubMed ID: 18644457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
    Rottoli P; Magi B; Perari MG; Liberatori S; Nikiforakis N; Bargagli E; Cianti R; Bini L; Pallini V
    Proteomics; 2005 Apr; 5(5):1423-30. PubMed ID: 15761959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?
    Liu DH; Cui W; Chen Q; Huang CM
    Scand J Clin Lab Invest; 2011 Nov; 71(7):593-7. PubMed ID: 21834618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis.
    Ziegenhagen MW; Schrum S; Zissel G; Zipfel PF; Schlaak M; Müller-Quernheim J
    J Investig Med; 1998 Jun; 46(5):223-31. PubMed ID: 9676055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
    Bloor CA; Knight RA; Kedia RK; Spiteri MA; Allen JT
    Am J Respir Crit Care Med; 2001 Jul; 164(2):265-72. PubMed ID: 11463599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis.
    Bennett D; Bargagli E; Bianchi N; Landi C; Fossi A; Fui A; Sestini P; Refini RM; Rottoli P
    Respir Physiol Neurobiol; 2020 Feb; 273():103323. PubMed ID: 31678459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
    Meyer KC; Cardoni A; Xiang ZZ
    J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
    Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
    Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
    Zhou LF; Jiang L; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):441-4. PubMed ID: 20979817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
    Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
    Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.